Articles producció científica> Medicina i Cirurgia

Reduced circulating sTWEAK levels are associated with metabolic syndrome in elderly individuals at high cardiovascular risk

  • Dades identificatives

    Identificador: imarina:831714
    Autors:
    Diaz-Lopez, AndresBullo, MonicaChacon, Matilde REstruch, RamonVendrell, JoanDiez-Espino, JavierFito, MontserratCorella, DoloresSalas-Salvado, Jordi
    Resum:
    The circulating soluble TNF-like weak inducer of apoptosis (sTWEAK) is a cytokine that modulates inflammatory and atherogenic reactions related to cardiometabolic risk. We investigated the association between sTWEAK levels and metabolic syndrome (MetS) and its components in older subjects at high cardiovascular risk.Cross-sectional analysis of 452 non-diabetic individuals (men and women aged 55-80 years) at high cardiovascular risk. MetS was defined by AHA/NHLBI and IDF criteria. Logistic regression analyses were used to estimate odds ratios (ORs) for MetS and its components by tertiles of serum sTWEAK concentrations measured by ELISA.sTWEAK concentrations were lower in subjects with MetS than in those without. In gender- and age-adjusted analyses, subjects in the lowest sTWEAK tertile had higher ORs for overall MetS [1.71 (95% CI, 1.07-2.72)] and its components abdominal obesity [2.01 (1.15-3.52)], hyperglycemia [1.94 (1.20-3.11)], and hypertriglyceridemia [1.73 (1.05-2.82)] than those in the upper tertile. These associations persisted after controlling for family history of diabetes and premature coronary heart disease, lifestyle, kidney function and other MetS components. sTWEAK concentrations decreased as the number of MetS components increased. Individuals in the lowest vs the upper sTWEAK tertile had an increased risk of disclosing greater number of MetS features. Adjusted ORs for individuals with 2 vs ?1, 3 vs ?1, and ?4 vs???1 MetS components were 2.60 (1.09-6.22), 2.83 (1.16-6.87) and 6.39 (2.42-16.85), respectively.In older subjects at high cardiovascular risk, reduced sTWEAK levels are associated with MetS: abdominal obesity, hypertriglyceridemia and hyperglycemia are the main contributors to this association.
  • Altres:

    Autor segons l'article: Diaz-Lopez, Andres; Bullo, Monica; Chacon, Matilde R; Estruch, Ramon; Vendrell, Joan; Diez-Espino, Javier; Fito, Montserrat; Corella, Dolores; Salas-Salvado, Jordi
    Departament: Medicina i Cirurgia Bioquímica i Biotecnologia
    Autor/s de la URV: Bulló Bonet, Mònica / Díaz López, Andres / Rodríguez Chacón, Matilde / Salas Salvadó, Jorge / VENDRELL FERRE, JOAN / Vendrell Ortega, Juan José
    Paraules clau: Stweak Metabolic syndrome Insulin resistance Cardiovascular risk Biomarkers
    Resum: The circulating soluble TNF-like weak inducer of apoptosis (sTWEAK) is a cytokine that modulates inflammatory and atherogenic reactions related to cardiometabolic risk. We investigated the association between sTWEAK levels and metabolic syndrome (MetS) and its components in older subjects at high cardiovascular risk.Cross-sectional analysis of 452 non-diabetic individuals (men and women aged 55-80 years) at high cardiovascular risk. MetS was defined by AHA/NHLBI and IDF criteria. Logistic regression analyses were used to estimate odds ratios (ORs) for MetS and its components by tertiles of serum sTWEAK concentrations measured by ELISA.sTWEAK concentrations were lower in subjects with MetS than in those without. In gender- and age-adjusted analyses, subjects in the lowest sTWEAK tertile had higher ORs for overall MetS [1.71 (95% CI, 1.07-2.72)] and its components abdominal obesity [2.01 (1.15-3.52)], hyperglycemia [1.94 (1.20-3.11)], and hypertriglyceridemia [1.73 (1.05-2.82)] than those in the upper tertile. These associations persisted after controlling for family history of diabetes and premature coronary heart disease, lifestyle, kidney function and other MetS components. sTWEAK concentrations decreased as the number of MetS components increased. Individuals in the lowest vs the upper sTWEAK tertile had an increased risk of disclosing greater number of MetS features. Adjusted ORs for individuals with 2 vs ?1, 3 vs ?1, and ?4 vs???1 MetS components were 2.60 (1.09-6.22), 2.83 (1.16-6.87) and 6.39 (2.42-16.85), respectively.In older subjects at high cardiovascular risk, reduced sTWEAK levels are associated with MetS: abdominal obesity, hypertriglyceridemia and hyperglycemia are the main contributors to this association.
    Àrees temàtiques: Saúde coletiva Medicina ii Medicina i Internal medicine Interdisciplinar Farmacia Endocrinology, diabetes and metabolism Endocrinology & metabolism Educação física Ciências biológicas ii Ciências biológicas i Cardiology and cardiovascular medicine Cardiac & cardiovascular systems Biotecnología
    Accès a la llicència d'ús: https://creativecommons.org/licenses/by/3.0/es/
    ISSN: 14752840
    Adreça de correu electrònic de l'autor: andres.diaz@urv.cat matilde.rodriguez@urv.cat monica.bullo@urv.cat jordi.salas@urv.cat juanjose.vendrell@urv.cat
    Identificador de l'autor: 0000-0002-7500-5629 0000-0002-0218-7046 0000-0003-2700-7459 0000-0002-6994-6115
    Data d'alta del registre: 2024-10-12
    Versió de l'article dipositat: info:eu-repo/semantics/publishedVersion
    Enllaç font original: https://cardiab.biomedcentral.com/articles/10.1186/1475-2840-13-51
    URL Document de llicència: https://repositori.urv.cat/ca/proteccio-de-dades/
    Referència a l'article segons font original: Cardiovascular Diabetology. 13 (1): 51-
    Referència de l'ítem segons les normes APA: Diaz-Lopez, Andres; Bullo, Monica; Chacon, Matilde R; Estruch, Ramon; Vendrell, Joan; Diez-Espino, Javier; Fito, Montserrat; Corella, Dolores; Salas-S (2014). Reduced circulating sTWEAK levels are associated with metabolic syndrome in elderly individuals at high cardiovascular risk. Cardiovascular Diabetology, 13(1), 51-. DOI: 10.1186/1475-2840-13-51
    DOI de l'article: 10.1186/1475-2840-13-51
    Entitat: Universitat Rovira i Virgili
    Any de publicació de la revista: 2014
    Tipus de publicació: Journal Publications
  • Paraules clau:

    Cardiac & Cardiovascular Systems,Cardiology and Cardiovascular Medicine,Endocrinology & Metabolism,Endocrinology, Diabetes and Metabolism,Internal Medicine
    Stweak
    Metabolic syndrome
    Insulin resistance
    Cardiovascular risk
    Biomarkers
    Saúde coletiva
    Medicina ii
    Medicina i
    Internal medicine
    Interdisciplinar
    Farmacia
    Endocrinology, diabetes and metabolism
    Endocrinology & metabolism
    Educação física
    Ciências biológicas ii
    Ciências biológicas i
    Cardiology and cardiovascular medicine
    Cardiac & cardiovascular systems
    Biotecnología
  • Documents:

  • Cerca a google

    Search to google scholar